Mechanical Ventilation of Patient with COPD ExacerbationDr.Mahmoud Abbas
Mechanical Ventilation of Patient with COPD Exacerbation lecture presented by Dr Andres Esteban at the Egyptian Critical care Summit 2015 held at Cairo, egypt.
The Egyptian Critical Care Summit is the leading medical event and exhibition for Intensive Care Medicine in Egypt.
Mechanical Ventilation of Patient with COPD ExacerbationDr.Mahmoud Abbas
Mechanical Ventilation of Patient with COPD Exacerbation lecture presented by Dr Andres Esteban at the Egyptian Critical care Summit 2015 held at Cairo, egypt.
The Egyptian Critical Care Summit is the leading medical event and exhibition for Intensive Care Medicine in Egypt.
Ventilatory management in obstructive airway diseasesVitrag Shah
Presentation on ventilatory management in COPD & Asthma
Updated information till 26/5/16
For powerpoint format, contact dr.vitrag@gmail.com
http://www.medicalgeek.com/presentation/36441-ventilatory-management-obstructive-airway-diseases-presentation.html
Ventilatory management in obstructive airway diseasesVitrag Shah
Presentation on ventilatory management in COPD & Asthma
Updated information till 26/5/16
For powerpoint format, contact dr.vitrag@gmail.com
http://www.medicalgeek.com/presentation/36441-ventilatory-management-obstructive-airway-diseases-presentation.html
How to ventilate COPD and ARDS in Intensive care unit. safe lung ventilation. PEEP, Tidal volume, mode of ventilation. limits of ventilation. ventilator alarms
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
4. Supportive care
Sedation and analgesia
• Intermittent injections are preferred over continuous infusions.
• Continuous infusions for patients requiring more injections.
• Some studies showed no sedation is superior to infusion.1
• Treat the underlying cause before sedating (pain/anxiety).
1. Strøm T, Martinussen T, Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised
trial. Lancet. 2010;375(9713):475-480. doi:10.1016/S0140-6736(09)62072-9 4Dr.Tarun Betha
7. Supportive care
Neuromuscular blockade (NMB)
• Improves oxygenation and reduces the oxygen requirements.
• Prolonged neuromuscular weakness is undesirable.
• Studies done on cisatracurium besylate, prefer continuous
infusion in initial 48hrs.
• Recommendation: early moderate to severe ARDS.2
2. Griffiths MJD, McAuley DF, Perkins GD, et al. Guidelines on the management of acute respiratory distress syndrome. BMJ Open Resp Res
2019;6:e000420. doi:10.1136/ bmjresp-2019-000420 7Dr.Tarun Betha
8. Supportive care
Highly catabolic.
Enteral feeding is preferred.
Patients fed in semi recumbent position with head
upright position
Nutritional support
8Dr.Tarun Betha
9. Supportive care
Hemodynamic monitoring
• CVP vs PAC were studied in trials.
• Both showed same results in terms of stay and mortality.
• PAC is associated with increased risk of arrythmias.
• Recommendation: use CVP for hemodynamic monitoring.
Griffiths MJD, McAuley DF, Perkins GD, et al. Guidelines on the management of acute respiratory distress syndrome. BMJ Open Resp Res
2019;6:e000420. doi:10.1136/ bmjresp-2019-000420 9Dr.Tarun Betha
10. Glucose monitoring:
Target 140-180mg/dL.
Avoid IIT.
GI prophylaxis with
Proton pump
inhibitors
DVT prophylaxis with
LMWH or heparin
Obtaining a secured
venous access.
ARDS
Supportive care
Source: UpToDate
10Dr.Tarun Betha
11. Hypoxia Management
• Using high fractions of O2.
• Decreased oxygen consumption.
• Improve oxygen delivery.
• Manipulate ventilatory support.
Invasive.
HFNC.
BPAP.
11Dr.Tarun Betha
12. Oxygenation considerations.
• Risk of oxygen toxicity.
• Starts at fio2 50% and increases as it approaches to fio2
100%.
• Atelectasis, hypercapnia, airway injury, parenchymal
or extra pulmonary injury.
• Reactive oxygen species.
Prevention:
14
Titrate fio2 to minimum to achieve - PaO2 60-65mm of Hg (SO2 90%)
Dr.Tarun Betha
13. Oxygenation considerations.
Strategies for reducing FiO2 requirements
• PEEP to reduce alveolar derecruitment.
• Protective ventilation strategies.
• Alveolar recruitment maneuvers- (CPAP 40cm for 60sec).
• Prone positioning.
• Alternate modes of ventilation, Inverse ratio ventilation.
• ECMO or ECCO2R.
• Diuresis.
• Bronchopulmonary hygiene.
• Liquid ventilation.
15Dr.Tarun Betha
14. Fluid management
• ARDS patients have increased vascular
permeability.
• Hydrostatic pressures increases
pulmonary fluid.
• This in turn will worsens the hypoxia.
• Trials showed conservative fluid therapy
is better than liberal fluid therapy.
• CVP targeted to <4mm Hg/ 5.4 cm of
H2O.
16Dr.Tarun Betha
15. 17
Other measures to improve
oxygenation
Decrease oxygen consumption
Improved
oxygen delivery
Transfuse only if
Hb<7
Dr.Tarun Betha
16. Invasive mechanical ventilation
indication:
moderate to
severe ards,
peep >/=5cm.
low tidal
volumes
6ml/kg.
target plateau
pressure
<30cm h2o.
peep
according to
ardsnet
protocol.
initial rr
≤35bpm.
18Dr.Tarun Betha
18. Volume limited
modes.
• Delivers a stable tidal volume.
• Trigger- ventilator or patient.
• Cycle termination- set volume is attained.
22
CMV AC IMV SIMV
Dr.Tarun Betha
19. Pressure limited
modes.
Pressure support
ventilation. (PSV)
• Set inspiratory pressure.
• RR, I:E ratio, PEEP and Fio2 are set.
• TV is variable.
• Cycle terminates once the set pressure is
delivered.
26
• flow-limited mode of ventilation.
• Set pressure support level (inspiratory
pressure level), applied PEEP, and FiO2.
• work of breathing is inversely proportional
to the pressure support level
Uses: weaning from ventilator.
Along with SIMV.Dr.Tarun Betha
20. APRV • High continuous positive airway pressure (P high) is delivered
for a long duration (T high) and then falls to a lower pressure (P
low) for a shorter duration (T low).
• P high to p low deflates the lungs and eliminates carbon
dioxide.
• P low to p high inflates the lungs.
• It is well tolerated hemodynamically.
• Decreases the peak airway pressure, improve alveolar
recruitment, increase ventilation of the dependent lung zones
and improve oxygenation
27Dr.Tarun Betha
21. Patients who are not improving
Supportive measures.
Alternative ventilator settings.
Inverse ratio ventilation.
Treat dyssynchrony
28Dr.Tarun Betha
23. ECMO
• ECMO – venoarterial (VA) and venovenous (VV).
• Indication in ARDS- selected adults suffering severe ARDS (defined as
a Lung Injury Score of 3 or more or pH <7.20.3
• Contraindication: bleeding diathesis, severe neurologic impairment.
• Side effects: Bleeding, thromboembolism, HIT, Neurological injury.
• Technique:
• blood is drained from the vascular system, circulated outside the body by a
mechanical pump, and reinfused into the circulation.
• outside the body, the blood passes through an oxygenator and heat exchanger.
• In the oxygenator, haemoglobin becomes fully saturated with oxygen, while carbon
dioxide (CO2) is removed.
30Dr.Tarun Betha